Life Science Imaging
The 3 Reasons
why NanoZoomer is the best solution.
Life Science Imaging
Panel discussion on the use of digital pathology for remote diagnosis
We invite you to join us for a roundtable discussion with pathologist Dr. Matthew Hanna and IT director Nikolas Stathonikos, facilitated by Scott Blakely, Business Development Manager for Whole Slide Imaging at Hamamatsu.
Our Statement for COVID-19
Remote Diagnoses and Digital Pathology An alternative solution during the current COVID-19 crisis

NanoZoomer tagline

Why NanoZoomer

Discover why our range of whole slide scanners are the perfect fit for any solution.

Solutions

Discover how NanoZoomers could be integrated into your workflow for optimal efficiencies.

Case Study

What do our customers and partners say about us?

NanoZoomer product range and its possibility

Important Notice:

Following products are CE marked under EU’s In Vitro Diagnostics Directive (IVDD) for in vitro diagnostic use:
NanoZoomer-SQ, NanoZoomer S210, NanoZoomer S60, NanoZoomer S360 including optional software e.g. NDP.view2 (U12388-21), NDP.view2 plus (U12388-22) and NDP.serve3 software (U13173-21, -22, -23).

 

In China, following products are registered for in vitro diagnostic use:
NanoZoomer-SQ, NanoZoomer S360, NanoZoomer S210 and NanoZoomer S60.

 

In Russia, following products are registered as medical device:
NanoZoomer-SQ, NanoZoomer S210 and NanoZoomer S60.

 

In Israel, following products are registered as medical device:
NanoZoomer-SQ, NanoZoomer S360, NanoZoomer S210 and NanoZoomer S60.

 

In the US, Japan and other countries, NanoZoomer is for research use only and is not permitted to use for clinical diagnostic purposes.

Scroll to Top